Evidence map›Paper›PMID 40261420›Full record

ArticleWorld journal of urology2025

SMART Stone Multidisciplinary Team (MDT) and patient care: recommendations for the adult high-risk kidney stone patient pathway.

Bhaskar Somani, Esteban Emiliani, Thomas Knoll, Giorgia Mandrile, Gill Rumsby, Cecile Acquaviva, Naeem Bhojani, Saeed Bin Hamri, Ewa Bres-Niewada, Niall F Davis and 11 more

Erratum issuedAbstract read
In one paragraph

Article in World journal of urology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. The future of endourology is now.World journal of urology · 2026
    Article
  6. Article
  7. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

21 authors.

Bhaskar SomaniSMART Stone Steering Committee, Southampton, UK. bhaskarsomani@yahoo.com.
Esteban EmilianiSMART Stone Steering Committee, Southampton, UK.
Thomas KnollSMART Stone Steering Committee, Southampton, UK.
Giorgia MandrileSMART Stone Steering Committee, Southampton, UK.
Gill RumsbySMART Stone Steering Committee, Southampton, UK.
Cecile AcquavivaService Biochimie et Biologie Moléculaire, Centre de Biologie et Pathologie Est, Unité Maladies Héréditaires du Métabolisme, CHU de Lyon, France.
Naeem BhojaniUniversity of Montreal Hospital Center, Université de Montréal, Montreal, QC, Canada.
Saeed Bin HamriDivision of Urology, King Abdulaziz Medical City, Riyadh, Saudi Arabia.
Ewa Bres-NiewadaDepartment of Urology, Faculty of Medicine, Roefler Memorial Hospital in Pruszkow, Lazarski University, Warsaw, Poland.
Niall F DavisDepartment of Urology, Beaumont Hospital, Dublin, Ireland.
Daniel G FusterDepartment of Nephrology and Hypertension, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
Sander F GarrelfsDepartment of Pediatric Nephrology, Emma Children'S Hospital, University of Amsterdam, Amsterdam, The Netherlands.
Vineet GauharDepartment of Urology, Ng Teng Fong General Hospital, Singapore, Singapore.
Shuzo HamamotoDepartment of Nephro-Urology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan.
Patrick Juliebø-JonesDepartment of Urology, Haukeland University Hospital, Bergen, Norway.
Marta LeporatiLaboratorio di Chimica Analitica e Calcolosi Renale, SC Laboratorio analisi, Azienda Ospedaliera Ordine Mauriziano di Torino, Turin, Piemonte, Italy.
Emmanuel LetavernierUMR S 1155, Sorbonne Université, 75020, Paris, France.
Tatsuya TakayamaDepartment of Urology, International University of Health and Welfare Hospital, Nasushiobara, Japan.
Lazaros TzelvesDepartment of Urology, Sismanogleio Hospital, National and Kapodistrian University of Athens, Athens, Greece.
Steffi Kar Kei YuenDepartment of Surgery, SH Ho Urology Centre, the Chinese University of Hong Kong, Hong Kong SAR, China.
Pietro Manuel FerraroSMART Stone Steering Committee, Southampton, UK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeThe SMART Stone Multidisciplinary Team (MDT) recommendations aim to provide guidance on the role of the MDT in the early identification, referral and assessment of adult high-risk recurrent kidney stone formers to advance patient care.

methodsRecommendations were developed by the expert Steering Committee (SC) comprising of three Urologists, one Nephrologist, and two Biochemists/Geneticists from the UK, Spain, Germany, and Italy. These recommendations were voted on by invited specialists via an online survey to determine their level of agreement, from 'strongly agree' to 'strongly disagree'. With an agreement threshold set at ≥ 70%, the SC reviewed the survey results, additional comments, and any areas of disagreement before finalizing the recommendations.

resultsA total of 44 recommendations were developed by the SC designed to support the set-up of an ideal MDT. Thirteen core recommendations were chosen as being highest priority and were voted on by 29 invited specialists from 19 countries across Europe, Canada, East Asia, South/Southeast Asia, and the Middle East. All 13 core recommendations reached the ≥ 70% agreement threshold. The remaining 31 recommendations were voted on by those specialists who opted-in to partake in the extended questionnaire. Fifteen specialists provided their responses from 14 different countries. All 31 recommendations reached the ≥ 70% agreement threshold.

conclusionsAn ideal MDT process can achieve comprehensive, high-quality, and coordinated patient care, which is especially useful for patients with complex stone diseases. A high level of agreement was reached in areas relating to the implementation of an ideal MDT in identifying high-risk stone formers.

Indexed as

Kidney CalculiPatient Care TeamAdultHumansComplex stone diseaseConsensusHigh-risk kidney stoneMultidisciplinary teamPatient care

Identifiers

PMID40261420
PMCPMC12586217

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.